Altitude illnesses.

Area of Science:

• Altitude Medicine
• Environmental Physiology
• Human Adaptation to Altitude

Background:

• Millions travel to and reside in high-altitude regions annually.
• High-altitude exposure can lead to acute high-altitude illnesses (HAIs) like acute mountain sickness (AMS), high-altitude cerebral edema (HACE), and high-altitude pulmonary edema (HAPE).
• Chronic mountain sickness (CMS) affects permanent high-altitude residents.

Purpose of the Study:

• To review the pathophysiology, clinical manifestations, and management of acute and chronic high-altitude illnesses.
• To highlight the importance of acclimatization, prevention, and prompt medical intervention.
• To identify areas for future research in diagnosis and susceptibility.

Main Methods:

• Review of existing literature on high-altitude illnesses.
• Synthesis of information on the mechanisms, symptoms, and treatments of HAIs and CMS.
• Discussion of current preventive strategies and diagnostic challenges.

Main Results:

• AMS is generally benign and self-limiting, linked to hypoxia-induced cerebral changes.
• HACE and HAPE are life-threatening conditions requiring immediate intervention, with symptoms including altered mental status, ataxia, and dyspnea.
• CMS is characterized by excessive erythrocytosis, with relocation recommended for severe cases.

Conclusions:

• Effective management of HAIs involves supplemental oxygen, descent, and pharmacological therapy.
• Preventive measures include slow ascent, pre-acclimatization, and prophylactic medications.
• Future research should prioritize objective diagnostic tools, susceptibility identification, and improved acclimatization strategies.